| Aurora At Home 931 Discovery Rd, Green Bay, WI, 54311 | |
| (920) 288-5100 |
News Archive
Natural Health Trends Corp., an international direct selling company, today announced that it has decided not to pursue a costly appeal of a delisting notice it received from The Nasdaq Stock Market on November 2, 2009. This decision was reached as part of the Company's overall strategy to improve cost-effectiveness and focus its resources on revenue-generation activities and support for member activities.
U-Systems, the leader in automated breast ultrasound, today announced it will showcase the recently introduced somo•v Platinum, an update to the somo•v® Automated Breast Ultrasound (ABUS) system, at the 22nd Annual National Interdisciplinary Breast Center Conference of the National Consortium of Breast Centers (NCBC).
OvaGene Oncology Inc., a biotechnology company specializing in the development and commercialization of personalized DNA-based diagnostics for gynecologic cancer, announced today the opening of its new clinical and research laboratory in Irvine, California. This state-of-the-art facility will serve as the central headquarters for operations, research, and molecular clinical lab testing.
Astronauts have been taking part in short spaceflight missions since 1961. They have only recently begun to spend significantly longer times in space, with missions extending for months, since the days of the Russian Mir space station (1986-2001) and extended stays on the International Space Station.
Discovery Laboratories, Inc., reports preliminary results from its Phase 2 clinical trial of Surfaxin® in children with Acute Respiratory Failure (ARF), a critical condition often caused in children by severe respiratory infections. The objective of the study was to evaluate the safety and tolerability of intratracheal administration of Surfaxin and to assess whether Surfaxin treatment could decrease the duration of mechanical ventilation in children with ARF.
› Verified 6 days ago
| Name | Aurora At Home |
|---|---|
| Location | 931 Discovery Rd, Green Bay, Wisconsin |
| Hospice ID | 521567 |
| Category | Part of a Home Health Agency |
| Ownership Type | Voluntary Non-profit - Private |
| Profit Type | NON-PROFIT |
| Accreditation Provider | Community Health Accreditation Partner (CHAP) |
| SSA county code | 040 |
News Archive
Natural Health Trends Corp., an international direct selling company, today announced that it has decided not to pursue a costly appeal of a delisting notice it received from The Nasdaq Stock Market on November 2, 2009. This decision was reached as part of the Company's overall strategy to improve cost-effectiveness and focus its resources on revenue-generation activities and support for member activities.
U-Systems, the leader in automated breast ultrasound, today announced it will showcase the recently introduced somo•v Platinum, an update to the somo•v® Automated Breast Ultrasound (ABUS) system, at the 22nd Annual National Interdisciplinary Breast Center Conference of the National Consortium of Breast Centers (NCBC).
OvaGene Oncology Inc., a biotechnology company specializing in the development and commercialization of personalized DNA-based diagnostics for gynecologic cancer, announced today the opening of its new clinical and research laboratory in Irvine, California. This state-of-the-art facility will serve as the central headquarters for operations, research, and molecular clinical lab testing.
Astronauts have been taking part in short spaceflight missions since 1961. They have only recently begun to spend significantly longer times in space, with missions extending for months, since the days of the Russian Mir space station (1986-2001) and extended stays on the International Space Station.
Discovery Laboratories, Inc., reports preliminary results from its Phase 2 clinical trial of Surfaxin® in children with Acute Respiratory Failure (ARF), a critical condition often caused in children by severe respiratory infections. The objective of the study was to evaluate the safety and tolerability of intratracheal administration of Surfaxin and to assess whether Surfaxin treatment could decrease the duration of mechanical ventilation in children with ARF.
› Verified 6 days ago
| NPI Number | 1417110214 |
| Organization Name | Visiting Nurse Association Of Wisconsin, Inc. |
| Address | 931 Discovery Rd Green Bay, Wisconsin, 54311 |
| Phone Number | (920)288-5100 |
News Archive
Natural Health Trends Corp., an international direct selling company, today announced that it has decided not to pursue a costly appeal of a delisting notice it received from The Nasdaq Stock Market on November 2, 2009. This decision was reached as part of the Company's overall strategy to improve cost-effectiveness and focus its resources on revenue-generation activities and support for member activities.
U-Systems, the leader in automated breast ultrasound, today announced it will showcase the recently introduced somo•v Platinum, an update to the somo•v® Automated Breast Ultrasound (ABUS) system, at the 22nd Annual National Interdisciplinary Breast Center Conference of the National Consortium of Breast Centers (NCBC).
OvaGene Oncology Inc., a biotechnology company specializing in the development and commercialization of personalized DNA-based diagnostics for gynecologic cancer, announced today the opening of its new clinical and research laboratory in Irvine, California. This state-of-the-art facility will serve as the central headquarters for operations, research, and molecular clinical lab testing.
Astronauts have been taking part in short spaceflight missions since 1961. They have only recently begun to spend significantly longer times in space, with missions extending for months, since the days of the Russian Mir space station (1986-2001) and extended stays on the International Space Station.
Discovery Laboratories, Inc., reports preliminary results from its Phase 2 clinical trial of Surfaxin® in children with Acute Respiratory Failure (ARF), a critical condition often caused in children by severe respiratory infections. The objective of the study was to evaluate the safety and tolerability of intratracheal administration of Surfaxin and to assess whether Surfaxin treatment could decrease the duration of mechanical ventilation in children with ARF.
› Verified 6 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 99.7 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 99.2 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 84.2 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 98.6 | 97.3 |
| Patients who got timely treatment for shortness of breath | 98.4 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 98.9 | 93.3 |
News Archive
Natural Health Trends Corp., an international direct selling company, today announced that it has decided not to pursue a costly appeal of a delisting notice it received from The Nasdaq Stock Market on November 2, 2009. This decision was reached as part of the Company's overall strategy to improve cost-effectiveness and focus its resources on revenue-generation activities and support for member activities.
U-Systems, the leader in automated breast ultrasound, today announced it will showcase the recently introduced somo•v Platinum, an update to the somo•v® Automated Breast Ultrasound (ABUS) system, at the 22nd Annual National Interdisciplinary Breast Center Conference of the National Consortium of Breast Centers (NCBC).
OvaGene Oncology Inc., a biotechnology company specializing in the development and commercialization of personalized DNA-based diagnostics for gynecologic cancer, announced today the opening of its new clinical and research laboratory in Irvine, California. This state-of-the-art facility will serve as the central headquarters for operations, research, and molecular clinical lab testing.
Astronauts have been taking part in short spaceflight missions since 1961. They have only recently begun to spend significantly longer times in space, with missions extending for months, since the days of the Russian Mir space station (1986-2001) and extended stays on the International Space Station.
Discovery Laboratories, Inc., reports preliminary results from its Phase 2 clinical trial of Surfaxin® in children with Acute Respiratory Failure (ARF), a critical condition often caused in children by severe respiratory infections. The objective of the study was to evaluate the safety and tolerability of intratracheal administration of Surfaxin and to assess whether Surfaxin treatment could decrease the duration of mechanical ventilation in children with ARF.
› Verified 6 days ago
| Home Health Aides | 4 |
| Counselors | 5 |
| Medical Social Workers | 4 |
| Physicians | 4 |
| Registered Nurses | 11 |
| Other Personnel | 3 |
| Total Employees | 31 |
|---|
News Archive
Natural Health Trends Corp., an international direct selling company, today announced that it has decided not to pursue a costly appeal of a delisting notice it received from The Nasdaq Stock Market on November 2, 2009. This decision was reached as part of the Company's overall strategy to improve cost-effectiveness and focus its resources on revenue-generation activities and support for member activities.
U-Systems, the leader in automated breast ultrasound, today announced it will showcase the recently introduced somo•v Platinum, an update to the somo•v® Automated Breast Ultrasound (ABUS) system, at the 22nd Annual National Interdisciplinary Breast Center Conference of the National Consortium of Breast Centers (NCBC).
OvaGene Oncology Inc., a biotechnology company specializing in the development and commercialization of personalized DNA-based diagnostics for gynecologic cancer, announced today the opening of its new clinical and research laboratory in Irvine, California. This state-of-the-art facility will serve as the central headquarters for operations, research, and molecular clinical lab testing.
Astronauts have been taking part in short spaceflight missions since 1961. They have only recently begun to spend significantly longer times in space, with missions extending for months, since the days of the Russian Mir space station (1986-2001) and extended stays on the International Space Station.
Discovery Laboratories, Inc., reports preliminary results from its Phase 2 clinical trial of Surfaxin® in children with Acute Respiratory Failure (ARF), a critical condition often caused in children by severe respiratory infections. The objective of the study was to evaluate the safety and tolerability of intratracheal administration of Surfaxin and to assess whether Surfaxin treatment could decrease the duration of mechanical ventilation in children with ARF.
› Verified 6 days ago
| Others | 34 |
| Total Volunteers | 34 |
|---|
News Archive
Natural Health Trends Corp., an international direct selling company, today announced that it has decided not to pursue a costly appeal of a delisting notice it received from The Nasdaq Stock Market on November 2, 2009. This decision was reached as part of the Company's overall strategy to improve cost-effectiveness and focus its resources on revenue-generation activities and support for member activities.
U-Systems, the leader in automated breast ultrasound, today announced it will showcase the recently introduced somo•v Platinum, an update to the somo•v® Automated Breast Ultrasound (ABUS) system, at the 22nd Annual National Interdisciplinary Breast Center Conference of the National Consortium of Breast Centers (NCBC).
OvaGene Oncology Inc., a biotechnology company specializing in the development and commercialization of personalized DNA-based diagnostics for gynecologic cancer, announced today the opening of its new clinical and research laboratory in Irvine, California. This state-of-the-art facility will serve as the central headquarters for operations, research, and molecular clinical lab testing.
Astronauts have been taking part in short spaceflight missions since 1961. They have only recently begun to spend significantly longer times in space, with missions extending for months, since the days of the Russian Mir space station (1986-2001) and extended stays on the International Space Station.
Discovery Laboratories, Inc., reports preliminary results from its Phase 2 clinical trial of Surfaxin® in children with Acute Respiratory Failure (ARF), a critical condition often caused in children by severe respiratory infections. The objective of the study was to evaluate the safety and tolerability of intratracheal administration of Surfaxin and to assess whether Surfaxin treatment could decrease the duration of mechanical ventilation in children with ARF.
› Verified 6 days ago
| Aurora At Home Location: 931 Discovery Rd, Green Bay, Wisconsin, 54311 Phone: (920) 288-5100 |
| Southerncare Green Bay Location: 1800 W Mason St Suite A, Green Bay, Wisconsin, 54303 Phone: (920) 288-5100 |
| Compassus Green Bay Location: 3237 Riverside Drive, Green Bay, Wisconsin, 54301 Phone: (920) 288-5100 |